Neuzumab 440mg Injection

About

Neuzumab 440mg Injection is a monoclonal antibody therapy primarily used in the treatment of certain cancers that overexpress specific receptors, such as HER2. This biologic medication works by selectively binding to these receptors on the surface of cancer cells, thereby inhibiting their growth and proliferation. By blocking the signaling pathways that promote cell division and survival, Neuzumab helps to slow down tumor progression and can induce apoptosis (programmed cell death) in susceptible cancer cells. Its targeted mechanism of action distinguishes it from traditional chemotherapy, often leading to a more favorable side effect profile.

Administered intravenously by a healthcare professional, Neuzumab is typically part of a comprehensive cancer treatment regimen, often in combination with chemotherapy or other targeted therapies. It is crucial for patients to undergo thorough diagnostic testing to confirm the overexpression of the target receptor before initiating treatment. Regular monitoring for potential adverse reactions, particularly cardiac function, is essential throughout the treatment period. The duration of therapy and specific dosing schedule are determined by the oncologist based on the type and stage of cancer, as well as the patient's overall health and response to treatment.

Uses

• Treatment of HER2-positive breast cancer.
• Management of HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.
• Used in certain other cancers with HER2 overexpression.
• Adjuvant therapy after surgery for early-stage HER2-positive breast cancer.

Directions For Use

This medication is administered as an intravenous infusion by a qualified healthcare professional in a clinical setting. The dosage and frequency will be determined by your doctor.

Benefits

• Provides targeted therapy for specific receptor-positive cancers.
• Can significantly improve survival rates in HER2-positive cancers.
• Often used in combination with chemotherapy for enhanced efficacy.
• May reduce the risk of cancer recurrence.
• Generally well-tolerated compared to conventional chemotherapy.
• Offers a personalized treatment approach based on tumor biology.

Side Effects

• Infusion-related reactions (fever, chills, headache)
• Nausea
• Diarrhea
• Fatigue
• Cardiotoxicity (heart problems)
• Rash
• Abdominal pain
• Muscle pain
• Anemia
• Neutropenia (low white blood cell count)
• Cough
• Headache

Safety Measures

• Alcohol - No direct interaction with alcohol is known, but general health advice to limit alcohol during cancer treatment applies.
• Pregnancy - Neuzumab can cause fetal harm or death. It is contraindicated in pregnancy. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is not recommended during treatment with Neuzumab and for at least 7 months after the last dose, due to potential harm to the infant.
• Liver - Use with caution in patients with pre-existing liver conditions. No specific dose adjustment is typically required, but monitoring is advised.
• Kidney - No specific dose adjustment is generally needed for renal impairment, but caution and monitoring are recommended in severe cases.
• Lung - Rare but serious pulmonary adverse events, including interstitial pneumonitis, can occur. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.